Loading company…
Scantox provides preclinical research and development services for drugs and medical devices.
Scantox conducts pharmacology and regulatory toxicology studies, including bioanalysis, histopathology and pharmacokinetics. It also offers vaccine, wound healing and local tolerance studies. Founded in 1977, the company is based in Denmark. In November 2023, it acquired the Neuropharmacology Division of QPS Austria GmbH.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in